Eating smaller meals, avoiding fatty foods, and making balanced food choices support both weight loss and comfort on the medication
The cross-sectional nature of this study means that no causal inferences can be made about the direction of the associations
The gradual dose escalation mirrors early clinical trials, where participants tolerated lower doses initially before progressing to the highest doses
For simplicity, we assume that the activations of GCL and GPX are equal, though that may not be the case
GHK-Cu therapy works by stimulating collagen, elastin, and hyaluronic acid production, and by activating hair follicles for improved growth, thickness, and strength
Wegovy at 2.4 mg is the licensed option for weight management, producing approximately 15% body weight loss and a 20% reduction in cardiovascular events in clinical trials